Advertisement

Index by Author

October 2000; 49 (10)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Akerblom, H K

    • Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group. Diabetes October 2000 49:1657-1665; doi:10.2337/diabetes.49.10.1657

  2. Anai, M

    • Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes October 2000 49:1700-1708; doi:10.2337/diabetes.49.10.1700

  3. Araki, T

    • Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes October 2000 49:1714-1723; doi:10.2337/diabetes.49.10.1714

  4. Armitage, N

    • NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes October 2000 49:1744-1747; doi:10.2337/diabetes.49.10.1744

  5. Asano, T

    • Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes October 2000 49:1700-1708; doi:10.2337/diabetes.49.10.1700

B

  1. Belaich, S

    • Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: further evidence for pluripotent pancreatic stem cells in humans. Diabetes October 2000 49:1671-1680; doi:10.2337/diabetes.49.10.1671

  2. Benjamin, C D

    • Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat. Diabetes October 2000 49:1666-1670; doi:10.2337/diabetes.49.10.1666

  3. Ben-Mahmud, B M

    • Activity of the glycosylating enzyme, core 2 GlcNAc (beta1,6) transferase, is higher in polymorphonuclear leukocytes from diabetic patients compared with age-matched control subjects: relevance to capillary occlusion in diabetic retinopathy. Diabetes October 2000 49:1724-1730; doi:10.2337/diabetes.49.10.1724

  4. Burcelin, R

    • Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes October 2000 49:1635-1642; doi:10.2337/diabetes.49.10.1635
    • Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice. Diabetes October 2000 49:1643-1648; doi:10.2337/diabetes.49.10.1643

C

  1. Cheung, W K

    • Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes October 2000 49:1731-1739; doi:10.2337/diabetes.49.10.1731

  2. Chibber, R

    • Activity of the glycosylating enzyme, core 2 GlcNAc (beta1,6) transferase, is higher in polymorphonuclear leukocytes from diabetic patients compared with age-matched control subjects: relevance to capillary occlusion in diabetic retinopathy. Diabetes October 2000 49:1724-1730; doi:10.2337/diabetes.49.10.1724

  3. Christ, E

    • Activity of the glycosylating enzyme, core 2 GlcNAc (beta1,6) transferase, is higher in polymorphonuclear leukocytes from diabetic patients compared with age-matched control subjects: relevance to capillary occlusion in diabetic retinopathy. Diabetes October 2000 49:1724-1730; doi:10.2337/diabetes.49.10.1724

  4. Christiansen, M P

    • Effect of dietary energy restriction on glucose production and substrate utilization in type 2 diabetes. Diabetes October 2000 49:1691-1699; doi:10.2337/diabetes.49.10.1691

  5. Collard, F

    • Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase. Diabetes October 2000 49:1627-1634; doi:10.2337/diabetes.49.10.1627

  6. Connell, J M

    • 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. Diabetes October 2000 49:1649-1656; doi:10.2337/diabetes.49.10.1649

  7. Coppini, D

    • Activity of the glycosylating enzyme, core 2 GlcNAc (beta1,6) transferase, is higher in polymorphonuclear leukocytes from diabetic patients compared with age-matched control subjects: relevance to capillary occlusion in diabetic retinopathy. Diabetes October 2000 49:1724-1730; doi:10.2337/diabetes.49.10.1724

D

  1. Daniel, P B

    • Glucagon stimulates expression of the inducible cAMP early repressor and suppresses insulin gene expression in pancreatic beta-cells. Diabetes October 2000 49:1681-1690; doi:10.2337/diabetes.49.10.1681

  2. Daniels, T L

    • GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65. Diabetes October 2000 49:1621-1626; doi:10.2337/diabetes.49.10.1621

  3. Delpierre, G

    • Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase. Diabetes October 2000 49:1627-1634; doi:10.2337/diabetes.49.10.1627

  4. Dolci, W

    • Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes October 2000 49:1635-1642; doi:10.2337/diabetes.49.10.1635
    • Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice. Diabetes October 2000 49:1643-1648; doi:10.2337/diabetes.49.10.1643

F

  1. Fujishiro, M

    • Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes October 2000 49:1700-1708; doi:10.2337/diabetes.49.10.1700

  2. Fukushima, Y

    • Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes October 2000 49:1700-1708; doi:10.2337/diabetes.49.10.1700

  3. Funaki, M

    • Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes October 2000 49:1700-1708; doi:10.2337/diabetes.49.10.1700

G

  1. Geng, Z

    • Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat. Diabetes October 2000 49:1666-1670; doi:10.2337/diabetes.49.10.1666

  2. Gmyr, V

    • Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: further evidence for pluripotent pancreatic stem cells in humans. Diabetes October 2000 49:1671-1680; doi:10.2337/diabetes.49.10.1671

  3. Gould, G W

    • 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. Diabetes October 2000 49:1649-1656; doi:10.2337/diabetes.49.10.1649

H

  1. Habener, J F

    • Glucagon stimulates expression of the inducible cAMP early repressor and suppresses insulin gene expression in pancreatic beta-cells. Diabetes October 2000 49:1681-1690; doi:10.2337/diabetes.49.10.1681

  2. Hellerstein, M K

    • Effect of dietary energy restriction on glucose production and substrate utilization in type 2 diabetes. Diabetes October 2000 49:1691-1699; doi:10.2337/diabetes.49.10.1691

  3. Hess, D M

    • Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat. Diabetes October 2000 49:1666-1670; doi:10.2337/diabetes.49.10.1666

  4. Hill, N J

    • NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes October 2000 49:1744-1747; doi:10.2337/diabetes.49.10.1744

  5. Horiuchi, S

    • Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes October 2000 49:1714-1723; doi:10.2337/diabetes.49.10.1714

  6. Hussain, M A

    • Glucagon stimulates expression of the inducible cAMP early repressor and suppresses insulin gene expression in pancreatic beta-cells. Diabetes October 2000 49:1681-1690; doi:10.2337/diabetes.49.10.1681

I

  1. Ilonen, J

    • Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group. Diabetes October 2000 49:1657-1665; doi:10.2337/diabetes.49.10.1657

  2. Inukai, K

    • Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes October 2000 49:1700-1708; doi:10.2337/diabetes.49.10.1700

K

  1. Kärkkäinen, P

    • Gene encoding the catalytic subunit p110beta of human phosphatidylinositol 3-kinase: cloning, genomic structure, and screening for variants in patients with type 2 diabetes. Diabetes October 2000 49:1740-1743; doi:10.2337/diabetes.49.10.1740

  2. Katagiri, H

    • Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes October 2000 49:1700-1708; doi:10.2337/diabetes.49.10.1700

  3. Kekäläinen, P

    • Gene encoding the catalytic subunit p110beta of human phosphatidylinositol 3-kinase: cloning, genomic structure, and screening for variants in patients with type 2 diabetes. Diabetes October 2000 49:1740-1743; doi:10.2337/diabetes.49.10.1740

  4. Kerr-Conte, J

    • Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: further evidence for pluripotent pancreatic stem cells in humans. Diabetes October 2000 49:1671-1680; doi:10.2337/diabetes.49.10.1671

  5. Kikuchi, M

    • Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes October 2000 49:1700-1708; doi:10.2337/diabetes.49.10.1700

  6. Knip, M

    • Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group. Diabetes October 2000 49:1657-1665; doi:10.2337/diabetes.49.10.1657

  7. Kohner, E M

    • Activity of the glycosylating enzyme, core 2 GlcNAc (beta1,6) transferase, is higher in polymorphonuclear leukocytes from diabetic patients compared with age-matched control subjects: relevance to capillary occlusion in diabetic retinopathy. Diabetes October 2000 49:1724-1730; doi:10.2337/diabetes.49.10.1724

  8. Kossila, M

    • Gene encoding the catalytic subunit p110beta of human phosphatidylinositol 3-kinase: cloning, genomic structure, and screening for variants in patients with type 2 diabetes. Diabetes October 2000 49:1740-1743; doi:10.2337/diabetes.49.10.1740

  9. Kover, K L

    • Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat. Diabetes October 2000 49:1666-1670; doi:10.2337/diabetes.49.10.1666

  10. Kuusisto, J

    • Gene encoding the catalytic subunit p110beta of human phosphatidylinositol 3-kinase: cloning, genomic structure, and screening for variants in patients with type 2 diabetes. Diabetes October 2000 49:1740-1743; doi:10.2337/diabetes.49.10.1740

L

  1. Laakso, M

    • Gene encoding the catalytic subunit p110beta of human phosphatidylinositol 3-kinase: cloning, genomic structure, and screening for variants in patients with type 2 diabetes. Diabetes October 2000 49:1740-1743; doi:10.2337/diabetes.49.10.1740

  2. Laukkanen, M O

    • Gene encoding the catalytic subunit p110beta of human phosphatidylinositol 3-kinase: cloning, genomic structure, and screening for variants in patients with type 2 diabetes. Diabetes October 2000 49:1740-1743; doi:10.2337/diabetes.49.10.1740

  3. Lecomte-Houcke, M

    • Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: further evidence for pluripotent pancreatic stem cells in humans. Diabetes October 2000 49:1671-1680; doi:10.2337/diabetes.49.10.1671

  4. Lefebvre, J

    • Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: further evidence for pluripotent pancreatic stem cells in humans. Diabetes October 2000 49:1671-1680; doi:10.2337/diabetes.49.10.1671

  5. Lernmark, A

    • GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65. Diabetes October 2000 49:1621-1626; doi:10.2337/diabetes.49.10.1621

  6. Leteurtre, E

    • Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: further evidence for pluripotent pancreatic stem cells in humans. Diabetes October 2000 49:1671-1680; doi:10.2337/diabetes.49.10.1671

  7. Linfoot, P A

    • Effect of dietary energy restriction on glucose production and substrate utilization in type 2 diabetes. Diabetes October 2000 49:1691-1699; doi:10.2337/diabetes.49.10.1691

  8. Ling, X

    • Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes October 2000 49:1714-1723; doi:10.2337/diabetes.49.10.1714

  9. Lyons, P A

    • NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes October 2000 49:1744-1747; doi:10.2337/diabetes.49.10.1744

M

  1. Matsumoto, K

    • Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes October 2000 49:1714-1723; doi:10.2337/diabetes.49.10.1714

  2. Miettinen, R

    • Gene encoding the catalytic subunit p110beta of human phosphatidylinositol 3-kinase: cloning, genomic structure, and screening for variants in patients with type 2 diabetes. Diabetes October 2000 49:1740-1743; doi:10.2337/diabetes.49.10.1740

  3. Moore, W V

    • Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat. Diabetes October 2000 49:1666-1670; doi:10.2337/diabetes.49.10.1666

N

  1. Nagai, R

    • Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes October 2000 49:1714-1723; doi:10.2337/diabetes.49.10.1714

  2. Neese, R A

    • Effect of dietary energy restriction on glucose production and substrate utilization in type 2 diabetes. Diabetes October 2000 49:1691-1699; doi:10.2337/diabetes.49.10.1691

  3. Nepom, G T

    • GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65. Diabetes October 2000 49:1621-1626; doi:10.2337/diabetes.49.10.1621

O

  1. Ogihara, T

    • Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes October 2000 49:1700-1708; doi:10.2337/diabetes.49.10.1700

  2. Oka, Y

    • Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes October 2000 49:1700-1708; doi:10.2337/diabetes.49.10.1700

  3. Onishi, Y

    • Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes October 2000 49:1700-1708; doi:10.2337/diabetes.49.10.1700

  4. Ono, H

    • Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes October 2000 49:1700-1708; doi:10.2337/diabetes.49.10.1700

  5. Ordög, T

    • Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes October 2000 49:1731-1739; doi:10.2337/diabetes.49.10.1731

P

  1. Paronen, J

    • Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group. Diabetes October 2000 49:1657-1665; doi:10.2337/diabetes.49.10.1657

  2. Pattou, F

    • Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: further evidence for pluripotent pancreatic stem cells in humans. Diabetes October 2000 49:1671-1680; doi:10.2337/diabetes.49.10.1671

  3. Peterson, L B

    • NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes October 2000 49:1744-1747; doi:10.2337/diabetes.49.10.1744

  4. Poehlman, E T

    • Impaired capacity to lose visceral adipose tissue during weight reduction in obese postmenopausal women with the Trp64Arg beta3-adrenoceptor gene variant. Diabetes October 2000 49:1709-1713; doi:10.2337/diabetes.49.10.1709

  5. Proye, C

    • Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: further evidence for pluripotent pancreatic stem cells in humans. Diabetes October 2000 49:1671-1680; doi:10.2337/diabetes.49.10.1671

R

  1. Reijonen, H

    • GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65. Diabetes October 2000 49:1621-1626; doi:10.2337/diabetes.49.10.1621

  2. Rider, M H

    • Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase. Diabetes October 2000 49:1627-1634; doi:10.2337/diabetes.49.10.1627

  3. Rissanen, J

    • Gene encoding the catalytic subunit p110beta of human phosphatidylinositol 3-kinase: cloning, genomic structure, and screening for variants in patients with type 2 diabetes. Diabetes October 2000 49:1740-1743; doi:10.2337/diabetes.49.10.1740

S

  1. Sakoda, H

    • Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes October 2000 49:1700-1708; doi:10.2337/diabetes.49.10.1700

  2. Salt, I P

    • 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. Diabetes October 2000 49:1649-1656; doi:10.2337/diabetes.49.10.1649

  3. Sanders, K M

    • Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes October 2000 49:1731-1739; doi:10.2337/diabetes.49.10.1731

  4. Santos, H

    • Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase. Diabetes October 2000 49:1627-1634; doi:10.2337/diabetes.49.10.1627

  5. Savilahti, E

    • Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group. Diabetes October 2000 49:1657-1665; doi:10.2337/diabetes.49.10.1657

  6. Shuldiner, A R

    • Impaired capacity to lose visceral adipose tissue during weight reduction in obese postmenopausal women with the Trp64Arg beta3-adrenoceptor gene variant. Diabetes October 2000 49:1709-1713; doi:10.2337/diabetes.49.10.1709

  7. Silver, K

    • Impaired capacity to lose visceral adipose tissue during weight reduction in obese postmenopausal women with the Trp64Arg beta3-adrenoceptor gene variant. Diabetes October 2000 49:1709-1713; doi:10.2337/diabetes.49.10.1709

  8. Sinkovic, M

    • Gene encoding the catalytic subunit p110beta of human phosphatidylinositol 3-kinase: cloning, genomic structure, and screening for variants in patients with type 2 diabetes. Diabetes October 2000 49:1740-1743; doi:10.2337/diabetes.49.10.1740

  9. Starling, R D

    • Impaired capacity to lose visceral adipose tissue during weight reduction in obese postmenopausal women with the Trp64Arg beta3-adrenoceptor gene variant. Diabetes October 2000 49:1709-1713; doi:10.2337/diabetes.49.10.1709

  10. Stroobant, V

    • Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase. Diabetes October 2000 49:1627-1634; doi:10.2337/diabetes.49.10.1627

  11. Suzuki, H

    • Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes October 2000 49:1714-1723; doi:10.2337/diabetes.49.10.1714

T

  1. Takayama, I

    • Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes October 2000 49:1731-1739; doi:10.2337/diabetes.49.10.1731

  2. Tchernof, A

    • Impaired capacity to lose visceral adipose tissue during weight reduction in obese postmenopausal women with the Trp64Arg beta3-adrenoceptor gene variant. Diabetes October 2000 49:1709-1713; doi:10.2337/diabetes.49.10.1709

  3. Thorens, B

    • Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes October 2000 49:1635-1642; doi:10.2337/diabetes.49.10.1635
    • Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice. Diabetes October 2000 49:1643-1648; doi:10.2337/diabetes.49.10.1643

  4. Todd, J A

    • NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes October 2000 49:1744-1747; doi:10.2337/diabetes.49.10.1744

  5. Turner, A

    • Impaired capacity to lose visceral adipose tissue during weight reduction in obese postmenopausal women with the Trp64Arg beta3-adrenoceptor gene variant. Diabetes October 2000 49:1709-1713; doi:10.2337/diabetes.49.10.1709

V

  1. Vaarala, O

    • Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group. Diabetes October 2000 49:1657-1665; doi:10.2337/diabetes.49.10.1657

  2. Vandewalle, B

    • Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: further evidence for pluripotent pancreatic stem cells in humans. Diabetes October 2000 49:1671-1680; doi:10.2337/diabetes.49.10.1671

  3. Van Schaftingen, E

    • Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase. Diabetes October 2000 49:1627-1634; doi:10.2337/diabetes.49.10.1627

  4. Vanstapel, F

    • Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase. Diabetes October 2000 49:1627-1634; doi:10.2337/diabetes.49.10.1627

  5. Vantyghem, M C

    • Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: further evidence for pluripotent pancreatic stem cells in humans. Diabetes October 2000 49:1671-1680; doi:10.2337/diabetes.49.10.1671

  6. Virtanen, S M

    • Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group. Diabetes October 2000 49:1657-1665; doi:10.2337/diabetes.49.10.1657

W

  1. Walston, J D

    • Impaired capacity to lose visceral adipose tissue during weight reduction in obese postmenopausal women with the Trp64Arg beta3-adrenoceptor gene variant. Diabetes October 2000 49:1709-1713; doi:10.2337/diabetes.49.10.1709

  2. Ward, S M

    • Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes October 2000 49:1731-1739; doi:10.2337/diabetes.49.10.1731

  3. Wicker, L S

    • NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes October 2000 49:1744-1747; doi:10.2337/diabetes.49.10.1744

Y

  1. Ylä-Herttuala, S

    • Gene encoding the catalytic subunit p110beta of human phosphatidylinositol 3-kinase: cloning, genomic structure, and screening for variants in patients with type 2 diabetes. Diabetes October 2000 49:1740-1743; doi:10.2337/diabetes.49.10.1740

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement